CARDIOVASCULAR ENDOCRINOLOGY Dual RAAS blockade has dual effects on outcome

Hiddo J. Lambers Heerspink; Dick de Zeeuw

doi:10.1038/nrendo.2013.65

CARDIOVASCULAR ENDOCRINOLOGY Dual RAAS blockade has dual effects on outcome

Hiddo J. Lambers Heerspink, Dick de Zeeuw^*

^*Corresponding author for this work

Groningen Kidney Center (GKC)

Research output: Contribution to journal › Editorial › Academic › peer-review

4 Citations (Scopus)

Abstract

Makani and colleagues report that dual blockade of the renin-angiotensin-aldosterone system is associated with harm despite previous studies showing that this approach decreases blood pressure and albuminuria. Do these results imply that we should abandon surrogate markers? Or should we become more creative in using them? Lambers Heerspink, H. J. & de Zeeuw, D. Nat. Rev. Endocrinol. 9, 261-263 (2013); published online 26 March 2013; doi:10.1038/nrendo.2013.65

Original language	English
Pages (from-to)	261-263
Number of pages	4
Journal	Nature reviews endocrinology
Volume	9
Issue number	5
DOIs	https://doi.org/10.1038/nrendo.2013.65
Publication status	Published - May-2013

Keywords

END-POINTS
TRIAL
RISK
TELMISARTAN
RAMIPRIL

Access to Document

10.1038/nrendo.2013.65

Handle.net

Persistent link

Cite this

@article{1d983431c25047b5ba9ab9d7c44613a7,

title = "CARDIOVASCULAR ENDOCRINOLOGY Dual RAAS blockade has dual effects on outcome",

abstract = "Makani and colleagues report that dual blockade of the renin-angiotensin-aldosterone system is associated with harm despite previous studies showing that this approach decreases blood pressure and albuminuria. Do these results imply that we should abandon surrogate markers? Or should we become more creative in using them? Lambers Heerspink, H. J. & de Zeeuw, D. Nat. Rev. Endocrinol. 9, 261-263 (2013); published online 26 March 2013; doi:10.1038/nrendo.2013.65",

keywords = "END-POINTS, TRIAL, RISK, TELMISARTAN, RAMIPRIL",

author = "Heerspink, {Hiddo J. Lambers} and {de Zeeuw}, Dick",

year = "2013",

month = may,

doi = "10.1038/nrendo.2013.65",

language = "English",

volume = "9",

pages = "261--263",

journal = "Nature reviews endocrinology",

issn = "1759-5029",

publisher = "Nature Publishing Group",

number = "5",

}

TY - JOUR

T1 - CARDIOVASCULAR ENDOCRINOLOGY Dual RAAS blockade has dual effects on outcome

AU - Heerspink, Hiddo J. Lambers

AU - de Zeeuw, Dick

PY - 2013/5

Y1 - 2013/5

N2 - Makani and colleagues report that dual blockade of the renin-angiotensin-aldosterone system is associated with harm despite previous studies showing that this approach decreases blood pressure and albuminuria. Do these results imply that we should abandon surrogate markers? Or should we become more creative in using them? Lambers Heerspink, H. J. & de Zeeuw, D. Nat. Rev. Endocrinol. 9, 261-263 (2013); published online 26 March 2013; doi:10.1038/nrendo.2013.65

AB - Makani and colleagues report that dual blockade of the renin-angiotensin-aldosterone system is associated with harm despite previous studies showing that this approach decreases blood pressure and albuminuria. Do these results imply that we should abandon surrogate markers? Or should we become more creative in using them? Lambers Heerspink, H. J. & de Zeeuw, D. Nat. Rev. Endocrinol. 9, 261-263 (2013); published online 26 March 2013; doi:10.1038/nrendo.2013.65

KW - END-POINTS

KW - TRIAL

KW - RISK

KW - TELMISARTAN

KW - RAMIPRIL

U2 - 10.1038/nrendo.2013.65

DO - 10.1038/nrendo.2013.65

M3 - Editorial

SN - 1759-5029

VL - 9

SP - 261

EP - 263

JO - Nature reviews endocrinology

JF - Nature reviews endocrinology

IS - 5

ER -

CARDIOVASCULAR ENDOCRINOLOGY Dual RAAS blockade has dual effects on outcome

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this